Amgen AMGN reported fourth-quarter 2024 adjusted earnings of $5.31 per share, which beat the Zacks Consensus Estimate of ...

Norfolk entrepreneur Tait Pollack from Norwich has credited sleep for saving his life after recovering from a life-threating illness following ...

Shares in Amazon ( AMZN) are up nearly 46% over the past year, with the stock hitting a record high closing price of $238.15 ...

February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...

COVID-19 vaccines were not associated with increased risk for thyroid diseases but were associated with increased risk for exacerbated hypothyroidism.

WASHINGTON: The Central Intelligence Agency on Saturday shifted its official stance on the origin of COVID-19, saying that it ...

Application is supported by results from the DEVOTE study, which suggested that two doses of Spinraza (nusinerse) 50 mg taken ...

Pune: While speaking on 67 cases of Guillain-Barre Syndrome (GBS) reported in Pune district, Assistant Health Officer, Pune Municipal Corporation Vaishali Jadhav said that a total of 67 cases of ...

In the Phase I dose escalation portion, which evaluated the combination in participants with small cell lung cancer, the ...

EXUMA Biotech, Corp., a clinical-stage biotechnology company discovering and developing cell and gene immunotherapies for solid and ...

AstraZeneca is a leader in cancer treatments with FDA-approved drugs. Read why AZN stock is still a 'Buy' and why the company’s future looks bright.

Even before the FDA's recent approval of Dato-DXd in breast cancer, analysts predicted sales of the antibody-drug conjugate ...